{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:39:13Z","timestamp":1766050753023,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"DOI":"10.1007\/s11604-024-01692-3","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T04:00:02Z","timestamp":1731556802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of nutritional parameters that may be associated with survival in patients with locally advanced non-small cell lung carcinoma receiving definitive concurrent chemoradiotherapy: retrospective study conducted in a tertiary pulmonary hospital"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6890-6413","authenticated-orcid":false,"given":"Emel","family":"Cireli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4019-3647","authenticated-orcid":false,"given":"Aydan","family":"Merto\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seher","family":"Susam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Yanarate\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"K\u0131rakl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"unstructured":"World Health Organisation (2022) Cancer. 2022. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer (Accessed: 7 June 2024)","key":"1692_CR1"},{"issue":"1","key":"1692_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"1692_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/annonc\/mdx222","volume":"28","author":"PE Postmus","year":"2017","unstructured":"Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:1\u201321.","journal-title":"Ann Oncol"},{"key":"1692_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2020-002838","author":"I Phillips","year":"2021","unstructured":"Phillips I, Allan L, Hug A, Westran N, Heinemann C, Hewish M, et al. Nutritional status and symptom burden in advanced non-small cell lung cancer: results of the dietetic assessment and intervention in lung cancer (DAIL) trial. BMJ Support Palliat Care. 2021. https:\/\/doi.org\/10.1136\/bmjspcare-2020-002838.","journal-title":"BMJ Support Palliat Care"},{"issue":"4","key":"1692_CR5","first-page":"601","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age. 2019;48(4):601.","journal-title":"Age"},{"issue":"5 Suppl","key":"1692_CR6","doi-asserted-by":"publisher","first-page":"990s","DOI":"10.1093\/jn\/127.5.990S","volume":"127","author":"IH Rosenberg","year":"1997","unstructured":"Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990s\u20131s.","journal-title":"J Nutr"},{"key":"1692_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","volume":"15","author":"LK Chen","year":"2014","unstructured":"Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95\u2013101. https:\/\/doi.org\/10.1016\/j.jamda.2013.11.025.","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"1692_CR8","first-page":"177","volume":"11","author":"V Santilli","year":"2014","unstructured":"Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin Cases Min Bone Metab. 2014;11(3):177\u201380.","journal-title":"Clin Cases Min Bone Metab"},{"issue":"3","key":"1692_CR9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3109\/0284186X.2014.953259","volume":"54","author":"GB Stene","year":"2015","unstructured":"Stene GB, Helbostad JL, Amundsen T, S\u00f8rhaug S, Hjelde H, Kaasa S, et al. Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Acta Oncol. 2015;54(3):340\u20138. https:\/\/doi.org\/10.3109\/0284186X.2014.953259.","journal-title":"Acta Oncol"},{"key":"1692_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12672-022-00576-0","volume":"13","author":"TY Lin","year":"2022","unstructured":"Lin TY, Chen YF, Wu WT, Han DS, Tsai IC, Chang KV, et al. Impact of sarcopenia on the prognosis and treatment of lung cancer: an umbrella review. Discov Oncol. 2022;13:115. https:\/\/doi.org\/10.1007\/s12672-022-00576-0.","journal-title":"Discov Oncol"},{"issue":"9","key":"1692_CR11","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.21873\/anticanres.13640","volume":"39","author":"J Buentzel","year":"2019","unstructured":"Buentzel J, Heinz J, Blekmann A, Bauer C, R\u00f6ver C, Bohnenberger H, et al. Sarcopenia as prognostic factor in lung cancer patients: a systematic review and meta-analysis. Anticancer Res. 2019;39(9):4603\u201312.","journal-title":"Anticancer Res"},{"issue":"20","key":"1692_CR12","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.12998\/wjcc.v10.i20.6927","volume":"10","author":"XL Pan","year":"2022","unstructured":"Pan XL, Li HJ, Li Z, Li ZL. Prognostic value of computed tomography derived skeletal muscle mass index in lung cancer: a meta-analysis. World J Clin Cases. 2022;10(20):6927\u201335.","journal-title":"World J Clin Cases"},{"issue":"1","key":"1692_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.chest.2019.04.115","volume":"156","author":"M Yang","year":"2019","unstructured":"Yang M, Shen Y, Tan L, Li W. Prognostic value of sarcopenia in lung cancer: a systematic review and meta-analysis. Chest. 2019;156(1):101\u201311. https:\/\/doi.org\/10.1016\/j.chest.2019.04.115.","journal-title":"Chest"},{"key":"1692_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ejso.2018.09.026","volume":"45","author":"HY Deng","year":"2019","unstructured":"Deng HY, Hou L, Zha P, Huang KL, Peng L. Sarcopenia is an independent unfavorable prognostic factor of non-small cell lung cancer after surgical resection: A comprehensive systematic review and meta-analysis. Eur J Surg Oncol. 2019;45:728\u201335. https:\/\/doi.org\/10.1016\/j.ejso.2018.09.026.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"1692_CR15","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.athoracsur.2019.04.090","volume":"108","author":"JM Nishimura","year":"2019","unstructured":"Nishimura JM, Ansari AZ, D\u2019Souza DM, Moffatt-Bruce SD, Merritt RE, Kneuertz PJ. Computed tomography-assessed skeletal muscle mass as a predictor of outcomes in lung cancer surgery. Ann Thorac Surg. 2019;108(5):1555\u201364. https:\/\/doi.org\/10.1016\/j.athoracsur.2019.04.090.","journal-title":"Ann Thorac Surg"},{"key":"1692_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2022.2110268","author":"E Karaman","year":"2022","unstructured":"Karaman E, Hursoy N, Goksel S. The effect of sarcopenia and metabolic PET-CT parameters on survival in locally advanced non-small cell lung carcinoma. Nutr Cancer. 2022. https:\/\/doi.org\/10.1080\/01635581.2022.2110268.","journal-title":"Nutr Cancer"},{"issue":"1","key":"1692_CR17","doi-asserted-by":"publisher","first-page":"11882","DOI":"10.1038\/s41598-021-91449-z","volume":"11","author":"K Katsui","year":"2021","unstructured":"Katsui K, Ogata T, Sugiyama S, Yoshio K, Kuroda M, Hiraki T, et al. Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis. Sci Rep. 2021;11(1):11882. https:\/\/doi.org\/10.1038\/s41598-021-91449-z. (Erratum in: Sci Rep. 2021;11(1):14586. 10.1038\/s41598-021-93955-6).","journal-title":"Sci Rep"},{"issue":"1","key":"1692_CR18","doi-asserted-by":"publisher","first-page":"10628","DOI":"10.1038\/s41598-021-90187-6","volume":"11","author":"R Mallet","year":"2021","unstructured":"Mallet R, Decazes P, Modzelewski R, Lequesne J, Vera P, Dubray B, et al. Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC. Sci Rep. 2021;11(1):10628. https:\/\/doi.org\/10.1038\/s41598-021-90187-6.","journal-title":"Sci Rep"},{"issue":"9","key":"1692_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.clon.2017.06.005","volume":"29","author":"JCS Bowden","year":"2017","unstructured":"Bowden JCS, Williams LJ, Simms A, Price A, Campbell S, Fallon MT, et al. Prediction of 90 day and overall survival after chemoradiotherapy for lung cancer: role of performance status and body composition. Clin Oncol. 2017;29(9):576\u201384. https:\/\/doi.org\/10.1016\/j.clon.2017.06.005.","journal-title":"Clin Oncol"},{"issue":"9","key":"1692_CR20","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/annonc\/mdx271","volume":"28","author":"F Bozzetti","year":"2017","unstructured":"Bozzetti F. Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. Ann Oncol. 2017;28(9):2107\u201318. https:\/\/doi.org\/10.1093\/annonc\/mdx271.","journal-title":"Ann Oncol"},{"key":"1692_CR21","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1007\/s00520-018-4563-9","volume":"27","author":"N Kiss","year":"2019","unstructured":"Kiss N, Beraldo J, Everitt S. Early skeletal muscle loss in non-small cell lung cancer patients receiving chemoradiation and relationship to survival. Support Care Cancer. 2019;27:2657\u201364. https:\/\/doi.org\/10.1007\/s00520-018-4563-9.","journal-title":"Support Care Cancer"},{"issue":"5","key":"1692_CR22","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/jcsm.12583","volume":"11","author":"TO Halvorsen","year":"2020","unstructured":"Halvorsen TO, Valan CD, Slaaen M, Gr\u00f8nberg BH. Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer. J Cachexia Sarcopenia Muscle. 2020;11(5):1283\u201390. https:\/\/doi.org\/10.1002\/jcsm.12583.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"1692_CR23","doi-asserted-by":"publisher","first-page":"11369","DOI":"10.1038\/s41598-018-29825-5","volume":"8","author":"BA Derstine","year":"2018","unstructured":"Derstine BA, Holcombe SA, Ross BE, Wang NC, Su GL, Wang SC. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci Rep. 2018;8(1):11369.","journal-title":"Sci Rep"},{"unstructured":"WHO body mass index (BMI) Classification 2010 https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/a-healthy-lifestyle---who-recommendations (Assessed 02 July 2024)","key":"1692_CR24"},{"key":"1692_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/nu12010186","volume":"12","author":"B Buchard","year":"2020","unstructured":"Buchard B, Boirie Y, Cassagnes L, Lamblin G, Coilly A, Abergel A. Assessment of malnutrition, sarcopenia and frailty in patients with cirrhosis: which tools should we use in clinical practice? Nutrients. 2020;12:186. https:\/\/doi.org\/10.3390\/nu12010186.","journal-title":"Nutrients"},{"key":"1692_CR26","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/jgs.16372","volume":"68","author":"S Bhasin","year":"2020","unstructured":"Bhasin S, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, et al. Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium. J Am Geriatr Soc. 2020;68:1410\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1692_CR27","first-page":"126","volume":"4","author":"G Bigman","year":"2021","unstructured":"Bigman G, As R. Implications of race and ethnicity in sarcopenia US national prevalence of sarcopenia by muscle mass, strength, and function indices. Gerontol Geriatr Res. 2021;4(1):126.","journal-title":"Gerontol Geriatr Res"},{"issue":"2","key":"1692_CR28","volume":"3","author":"C Jeng","year":"2018","unstructured":"Jeng C, Zhao LJ, Wu K, Zhou Y, Chen T, Deng HW. Race and socioeconomic effect on sarcopenia and sarcopenic obesity in the Louisiana Osteoporosis Study (LOS). JCSM Clin Rep. 2018;3(2): e00027.","journal-title":"JCSM Clin Rep"},{"issue":"1","key":"1692_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003697","volume":"4","author":"J Collins","year":"2014","unstructured":"Collins J, Noble S, Chester J, Coles B, Byrne A. The assessment and impact of sarcopenia in lung cancer: a systematic literature review. BMJ Open. 2014;4(1): e003697. https:\/\/doi.org\/10.1136\/bmjopen-2013-003697.","journal-title":"BMJ Open"},{"issue":"10","key":"1692_CR30","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/gerona\/gls071","volume":"67","author":"YS Kim","year":"2012","unstructured":"Kim YS, Lee Y, Chung YS, Lee DJ, Joo NS, Hong D, et al. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci. 2012;67(10):1107\u201313. https:\/\/doi.org\/10.1093\/gerona\/gls071.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"1692_CR31","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/jcsm.12958","volume":"13","author":"S Seino","year":"2022","unstructured":"Seino S, Kitamura A, Abe T, Taniguchi Y, Murayama H, Amano H, et al. Dose-response relationships of sarcopenia parameters with incident disability and mortality in older Japanese adults. J Cachexia Sarcopenia Muscle. 2022;13(2):932\u201344. https:\/\/doi.org\/10.1002\/jcsm.12958.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"1692_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.31083\/j.fbl2704129","volume":"27","author":"I Phillips","year":"2022","unstructured":"Phillips I, Stares M, Allan L, Sayers J, Skipworth R, Laird B. Optimising outcomes in non small cell lung cancer: Targeting cancer cachexia. Front Biosci. 2022;27(4):129. https:\/\/doi.org\/10.31083\/j.fbl2704129.","journal-title":"Front Biosci"},{"issue":"3","key":"1692_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12149-019-01429-7","volume":"34","author":"C Zhou","year":"2020","unstructured":"Zhou C, Foster B, Hagge R, Foster C, Lenchik L, Chaudhari AJ, et al. Opportunistic body composition evaluation in patients with esophageal adenocarcinoma: association of survival with 18 F-FDG PET\/CT muscle metrics. Ann Nucl Med. 2020;34(3):174\u201381. https:\/\/doi.org\/10.1007\/s12149-019-01429-7.","journal-title":"Ann Nucl Med"},{"key":"1692_CR34","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3389\/fimmu.2018.01055","volume":"9","author":"Y Alwarawrah","year":"2018","unstructured":"Alwarawrah Y, Kiernan K, MacIver NJ. Changes in nutritional status impact immune cell metabolism and function. Front Immunol. 2018;9:1055. https:\/\/doi.org\/10.3389\/fimmu.2018.01055.","journal-title":"Front Immunol"},{"issue":"4","key":"1692_CR35","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/jcsm.12430","volume":"10","author":"JY Kim","year":"2019","unstructured":"Kim JY, Jun DW, Choi J, Nam E, Son D, Choi YY. Psoas muscle fluorine-18-labelled fluoro-2-deoxy-d-glucose uptake associated with the incidence of existing and incipient metabolic derangement. J Cachexia Sarcopenia Muscle. 2019;10(4):894\u2013902. https:\/\/doi.org\/10.1002\/jcsm.12430.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1692_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101883","volume":"86","author":"G Coletta","year":"2023","unstructured":"Coletta G, Phillips SM. An elusive consensus definition of sarcopenia impedes research and clinical treatment: A narrative review. Ageing Res Rev. 2023;86: 101883. https:\/\/doi.org\/10.1016\/j.arr.2023.101883.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"1692_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MCO.0000000000000119","volume":"18","author":"T Cederholm","year":"2015","unstructured":"Cederholm T, Morley JE. Sarcopenia: The new definitions. Curr Opin Clin Nutr Metab Care. 2015;18(1):1\u20134.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1692_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jpen.2415","author":"A Surov","year":"2022","unstructured":"Surov A, Wienke A. Prevalence of sarcopenia in patients with solid tumors: A meta-analysis based on 81,814 patients. JPEN J Parenter Enteral Nutr. 2022. https:\/\/doi.org\/10.1002\/jpen.2415.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"3","key":"1692_CR39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/1457496917748221","volume":"107","author":"EY Kim","year":"2017","unstructured":"Kim EY, Lee HY, Kim KW, Lee JI, Kim YS, Choi WJ, et al. Preoperative computed tomography-determined sarcopenia and postoperative outcome after surgery for non-small cell lung cancer. Scand J Surg. 2017;107(3):244\u201351.","journal-title":"Scand J Surg"},{"issue":"8","key":"1692_CR40","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1007\/s10147-021-01927-7","volume":"26","author":"K Katsui","year":"2021","unstructured":"Katsui K, Ogata T, Watanabe K, Yoshio K, Kuroda M, Yamane M, et al. Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer. Int J Clin Oncol. 2021;26(8):1450\u201360. https:\/\/doi.org\/10.1007\/s10147-021-01927-7.","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"1692_CR41","doi-asserted-by":"publisher","first-page":"ivad020","DOI":"10.1093\/icvts\/ivad020","volume":"36","author":"K Watanabe","year":"2023","unstructured":"Watanabe K, Kinoshita F, Takenaka T, Nagano T, Oku Y, Kosai K, et al. Skeletal muscle area predicts the outcomes of non-small-cell lung cancer after trimodality therapy. Interdiscip Cardiovasc Thorac Surg. 2023;36(2):ivad020. https:\/\/doi.org\/10.1093\/icvts\/ivad020.","journal-title":"Interdiscip Cardiovasc Thorac Surg"},{"issue":"12","key":"1692_CR42","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. JCO. 2013;31(12):1539\u201347. https:\/\/doi.org\/10.1200\/JCO.2012.45.2722.","journal-title":"JCO"},{"key":"1692_CR43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.lungcan.2016.11.017","volume":"104","author":"VK Lam","year":"2017","unstructured":"Lam VK, Bentzen SM, Mohindra P, Nichols EM, Bhooshan N, Vyfhuis M, et al. Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC). Lung Cancer. 2017;104:52\u20137. https:\/\/doi.org\/10.1016\/j.lungcan.2016.11.017.","journal-title":"Lung Cancer"},{"issue":"12","key":"1692_CR44","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1200\/JCO.2015.63.6043","volume":"34","author":"S Blauwhoff-Buskermolen","year":"2016","unstructured":"Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA, den Braver NR, Berkhof J, Langius JA, et al. Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. JCO. 2016;34(12):1339\u201344.","journal-title":"JCO"},{"key":"1692_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.lungcan.2016.10.017","volume":"102","author":"A Gupta","year":"2016","unstructured":"Gupta A, Majumder K, Arora N, Mayo HG, Singh PP, Beg MS, et al. Premorbid body mass index and mortality in patients with lung cancer: A systematic review and meta-analysis. Lung Cancer. 2016;102:49\u201359. https:\/\/doi.org\/10.1016\/j.lungcan.2016.10.017.","journal-title":"Lung Cancer"},{"issue":"7","key":"1692_CR46","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629\u201335. https:\/\/doi.org\/10.1016\/S1470-2045(08)70153-0.","journal-title":"Lancet Oncol"},{"issue":"12","key":"1692_CR47","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/thx.2011.158972","volume":"66","author":"AL Rich","year":"2011","unstructured":"Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, et al. Inequalities in outcomes for non-small cell lung cancer: The influence of clinical characteristics and features of the local lung cancer service. Thorax. 2011;66(12):1078\u201384. https:\/\/doi.org\/10.1136\/thx.2011.158972.","journal-title":"Thorax"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-024-01692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-024-01692-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-024-01692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T04:55:01Z","timestamp":1731560101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-024-01692-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":47,"alternative-id":["1692"],"URL":"https:\/\/doi.org\/10.1007\/s11604-024-01692-3","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"type":"print","value":"1867-1071"},{"type":"electronic","value":"1867-108X"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors has conflicts of interest that may have influenced either the conduct or the presentation of the research. The manuscript has been read and approved by all the authors; the requirements for authorship have been met and each author believes that the manuscript represents honest work and information is not provided in another form. No funding was taken to conduct the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed according to the Helsinki declaration, and it was approved by the Ethics Committee of Health Sciences University Izmir Chest Diseases and Surgery Training Hospital (EPK no: E-49109414-604.02.02).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The study was retrospective and informed consent was not necessary.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}